Beuy Joob1, Viroj Wiwanitkit2. 1. Sanitation 1 Medical Academic Center, Bangkok, Thailand. Electronic address: beuyjoob@hotmail.com. 2. Dr DY Patil University, Pune, India, and Hainan Medical University, Haikou, China.
To the Editor: We appreciate the additional information from Jimenez-Cauhe et al on our report on a skin rash in a patient with COVID-19. Jimenez-Cauhe et al showed a clinical picture of a skin rash at the axilla of a patient. As a new emerging virus infection, the dermatologic presentation is an interesting clinical feature.The skin rash in our previous publication that looked like the skin rash in dengue copresented with thrombocytopenia in a patient with COVID-19. Nevertheless, there is also the possibility that there might be other forms of COVID-19skin rashes. In a previous report on a classical coronavirus infection, the rash appeared to be recurrent; “target-like purpuric plaques” was reported as another clinical presentation.In the present clinical case by Jimenez-Cauhe et al, the rash might be a coincidence or an actual COVID-19–induced skin rash. Whether the lesion described by Jimenez- Cauhe et al is related to the pathophysiologic process of COVID-19 or not should be further studied.
Authors: Juan Jimenez-Cauhe; Daniel Ortega-Quijano; Marta Prieto-Barrios; Oscar M Moreno-Arrones; Diego Fernandez-Nieto Journal: J Am Acad Dermatol Date: 2020-04-10 Impact factor: 11.527
Authors: Jacek Baj; Hanna Karakuła-Juchnowicz; Grzegorz Teresiński; Grzegorz Buszewicz; Marzanna Ciesielka; Ryszard Sitarz; Alicja Forma; Kaja Karakuła; Wojciech Flieger; Piero Portincasa; Ryszard Maciejewski Journal: J Clin Med Date: 2020-06-05 Impact factor: 4.241
Authors: N Skroza; N Bernardini; V Balduzzi; A Mambrin; A Marchesiello; S Michelini; E Tolino; I Proietti; C Di Cristofano; V Petrozza; C Potenza Journal: J Eur Acad Dermatol Venereol Date: 2020-06-15 Impact factor: 9.228